Community screening for rheumatic diseases in Cyprus: a university–patient–scientific partnership
Abstract
Issue: In rheumatic diseases, leading causes of disability and reduced work participation, prompt detection is critical to limiting long-term burden. In Cyprus, and similar settings, limited specialist capacity and lack of structured primary care screening may contribute to delayed recognition and referral.
Description: rECORD brought together researchers, clinicians and patient representatives to adapt the EpiReumaPt screening tool for the Cypriot context through cultural adaptation and expert consensus. Three consecutive pilot studies were conducted in rural community settings: the first assessed item performance, while the second (N = 191) and third (N = 82) evaluated diagnostic accuracy. All followed a two-phase same-day process: screening by trained nursing students, followed by blinded clinical assessment by specialists for all screen-positive and 20% of screen-negative participants.
Results: The structured tool, covering symptoms and disease-specific screening pathways across major RMD categories, demonstrated feasibility and case-finding capacity with high pooled sensitivity (∼95%, 95% exact CI 89–98), supporting its role as referral tool. While improved compared with the original prototype, specificity was moderate (∼46%, 95% CI 19–75) and less precise, as a few screen-negative underwent verification. Implementation confirmed usability by trained non-specialist staff and high participation among screen-positive individuals, while also noting challenges in referral uptake among screen-negative cases.
Lessons: Community-based RMD screening can support earlier identification and referral, but its impact depends on primary care readiness and training, as well as specialist system capacity. The rECORD experience illustrates the value of partnerships in adapting evidence-based tools to local contexts. Screening could be embedded in strengthened referral pathways but primary care training and the potential for over-referral must consider available specialist capacity.
Key messages: • A culturally adapted RMD screening tool showed strong case-finding potential for use in community and primary care settings.
• Screening improves early recognition only when linked to trained primary care teams, effective referral pathways and sufficient specialist capacity.
Related
- Building a community-academic partnership in public housing: Lessons from applying the CBPR Partnership Readiness Model
- Extending Problem and Solution Trees: A Participatory Method for Community Partnership Development
- Deploying Local Large Language Models for Automated Article Screening in Scientific Literature Reviews
- [Knowledge, attitudes and misinformation about institutional breastfeeding support in a university community: Implications for primary and community care].
- Blood donation knowledge, attitudes, previous donation and student community engagement at Rajshahi University, Bangladesh: a cross-sectional study
BibTeX
@article{nikolaou2026community,
title = {{Community screening for rheumatic diseases in Cyprus: a university–patient–scientific partnership}},
author = {N Nikolaou and V Hadjiroussos and C Nicolaou and M Michaelides and A Panayiotou and N Middleton and rECORD project team},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.1569},
url = {https://doi.org/10.1093/eurpub/ckag169.1569},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Community screening for rheumatic diseases in Cyprus: a university–patient–scientific partnership
AU - N Nikolaou
AU - V Hadjiroussos
AU - C Nicolaou
AU - M Michaelides
AU - A Panayiotou
AU - N Middleton
AU - rECORD project team
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.1569
UR - https://doi.org/10.1093/eurpub/ckag169.1569
AB - Issue: In rheumatic diseases, leading causes of disability and reduced work participation, prompt detection is critical to limiting long-term burden. In Cyprus, and similar settings, limited specialist capacity and lack of structured primary care screening may contribute to delayed recognition and referral. Description: rECORD brought together researchers, clinicians and patient representatives to adapt the EpiReumaPt screening tool for the Cypriot context through cultural adaptation and expert consensus. Three consecutive pilot studies were conducted in rural community settings: the first assessed item performance, while the second (N = 191) and third (N = 82) evaluated diagnostic accuracy. All followed a two-phase same-day process: screening by trained nursing students, followed by blinded clinical assessment by specialists for all screen-positive and 20% of screen-negative participants. Results: The structured tool, covering symptoms and disease-specific screening pathways across major RMD categories, demonstrated feasibility and case-finding capacity with high pooled sensitivity (∼95%, 95% exact CI 89–98), supporting its role as referral tool. While improved compared with the original prototype, specificity was moderate (∼46%, 95% CI 19–75) and less precise, as a few screen-negative underwent verification. Implementation confirmed usability by trained non-specialist staff and high participation among screen-positive individuals, while also noting challenges in referral uptake among screen-negative cases. Lessons: Community-based RMD screening can support earlier identification and referral, but its impact depends on primary care readiness and training, as well as specialist system capacity. The rECORD experience illustrates the value of partnerships in adapting evidence-based tools to local contexts. Screening could be embedded in strengthened referral pathways but primary care training and the potential for over-referral must consider available specialist capacity. Key messages: • A culturally adapted RMD screening tool showed strong case-finding potential for use in community and primary care settings. • Screening improves early recognition only when linked to trained primary care teams, effective referral pathways and sufficient specialist capacity.
SN - 1101-1262
SN - 1464-360X
ER -